Postoperative Blood Loss in Coronary Surgery

Although in many cardiac surgery centers pharmacological strategies based on fibrinolytic inhibitors are used on a routine basis, detailed knowledge of fibrinolysis during various settings of coronary surgery is still limited. Sixty-five patients scheduled for coronary surgery were randomized into 3 groups: group A - conventional coronary artery bypass grafting, group B - off-pump surgery, and group C - coronary artery bypass grafting with modified, rheoparin coated cardiopulmonary bypass with the avoidance of reinfusion of cardiotomy blood into the circuit. The sampling time points for rotation thromboelastographic evaluations were as follows: preoperatively, 15 minutes after sternotomy, on the completion of peripheral bypass anastomoses, at the end of the procedures, and 24 hours after the end of surgery. D-dimer levels were evaluated before surgery, at the end of procedures, and 24 hours after surgery. Thromboelastographic signs of fibrinolysis (evaluated by Lysis Onset Time-intergroup differences at 60 and 150 minutes of assessment: P = 0.003 and P < 0.001, respectively) were clearly detectable during cardiopulmonary bypass in group A, but not at any time in groups B and C. At the other sampling times all thromboelastographic parameters were similar in all groups. In group A, no exceptional bleeding tendency (during 24 hours), as compared to groups B and C (geometric means and 95% confidence intervals: group A: 686.7 [570.8; 826.1] mL, group B: 555.3 [441.3; 698.9] mL, group C: 775.6 [645.1; 932.3] mL, P = 0.157), and no significant correlations between Lysis Onset Time, postoperative blood loss, and D-dimer levels were found. No significant differences in postoperative blood loss related to cardiac surgeons and assistant surgeons were detected. Thromboelastographic signs of increased fibrinolysis were detectable in the important proportion of coronary surgery patients operated on with the use of conventional cardio-pulmonary bypass, but not in off-pump patients and those operated on with the biocompatible surface-modified circuit without reinfusion of cardiotomy suction blood. These signs resolved spontaneously at the end of surgery and were not associated with increased postoperative bleeding. No significant correlation with D-dimer levels was found.

[1]  M. Malý,et al.  Fibrinolysis in coronary artery surgery: detection by thromboelastography. , 2007, Interactive cardiovascular and thoracic surgery.

[2]  J. Albes,et al.  Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  O. Alfieri,et al.  Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement. , 2007, The Annals of thoracic surgery.

[4]  Z. Straka,et al.  Off-pump versus on-pump coronary artery surgery. , 2007, International heart journal.

[5]  G. Angelini,et al.  A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. , 2006, The Journal of thoracic and cardiovascular surgery.

[6]  T. Gardner,et al.  An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. , 2006, The Journal of thoracic and cardiovascular surgery.

[7]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[8]  S. Brister,et al.  Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques. , 2006, The Journal of thoracic and cardiovascular surgery.

[9]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[10]  J. Remadi,et al.  Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass. , 2006, American heart journal.

[11]  M. Tarkka,et al.  Effects of Half-dose Aprotinin in Off-pump Coronary Artery Bypass Grafting , 2006, World Journal of Surgery.

[12]  Z. Straka,et al.  Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  J. Dunning,et al.  Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? , 2005, Interactive cardiovascular and thoracic surgery.

[14]  J. Vaage,et al.  Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study. , 2005, The Annals of thoracic surgery.

[15]  D. Bainbridge,et al.  Does Off-pump Coronary Artery Bypass Reduce Mortality, Morbidity, and Resource Utilization When Compared with Conventional Coronary Artery Bypass? A Meta-analysis of Randomized Trials , 2005, Anesthesiology.

[16]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.

[17]  O. Alfieri,et al.  Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. , 2004, The Journal of thoracic and cardiovascular surgery.

[18]  Z. Straka,et al.  Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. , 2003, The Journal of cardiovascular surgery.

[19]  O. Alfieri,et al.  Activation of Coagulation and Fibrinolysis during Coronary Surgery: On-pump versus Off-pump Techniques , 2001, Anesthesiology.

[20]  O. Alfieri,et al.  Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. , 2001, The Annals of thoracic surgery.

[21]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[22]  C. Whitten,et al.  THROMBELASTOGRAPHIC FIBRINOLYSIS DOES NOT CORRELATE WITH LEVELS OF D-DIMERS AFTER CARDIOPULMONARY BYPASS , 1991 .